These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17005918)

  • 1. The nitric oxide-donating pravastatin derivative, NCX 6550 [(1S-[1alpha(betaS*, deltaS*), 2alpha, 6alpha, 8beta-(R*), 8a alpha]]-1,2,6,7,8,8a-Hexahydro-beta, delta, 6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphtalene-heptanoic acid 4-(nitrooxy)butyl ester)], reduces splenocyte adhesion and reactive oxygen species generation in normal and atherosclerotic mice.
    Dever G; Spickett CM; Kennedy S; Rush C; Tennant G; Monopoli A; Wainwright CL
    J Pharmacol Exp Ther; 2007 Jan; 320(1):419-26. PubMed ID: 17005918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipid chlorohydrin induces leukocyte adhesion to ApoE-/- mouse arteries via upregulation of P-selectin.
    Dever GJ; Benson R; Wainwright CL; Kennedy S; Spickett CM
    Free Radic Biol Med; 2008 Feb; 44(3):452-63. PubMed ID: 18005671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.
    Momi S; Impagnatiello F; Guzzetta M; Caracchini R; Guglielmini G; Olivieri R; Monopoli A; Gresele P
    Eur J Pharmacol; 2007 Sep; 570(1-3):115-24. PubMed ID: 17632098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice.
    Baumhäkel M; Schlimmer N; Büyükafsar K; Arikan O; Böhm M
    J Pharmacol Exp Ther; 2008 Jun; 325(3):818-23. PubMed ID: 18364472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nitric oxide-donating pravastatin, NCX 6550, inhibits cytokine release and NF-κB activation while enhancing PPARγ expression in human monocyte/macrophages.
    Amoruso A; Bardelli C; Fresu LG; Poletti E; Palma A; Federici Canova D; Zeng HW; Ongini E; Brunelleschi S
    Pharmacol Res; 2010 Nov; 62(5):391-9. PubMed ID: 20670683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion.
    Wan JB; Lee SM; Wang JD; Wang N; He CW; Wang YT; Kang JX
    J Agric Food Chem; 2009 Aug; 57(15):6692-7. PubMed ID: 19722574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
    Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
    Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
    J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of endothelial function by systemic transfusion of vascular progenitor cells.
    Wassmann S; Werner N; Czech T; Nickenig G
    Circ Res; 2006 Oct; 99(8):e74-83. PubMed ID: 16990568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
    Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
    Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression.
    Takaya T; Hirata K; Yamashita T; Shinohara M; Sasaki N; Inoue N; Yada T; Goto M; Fukatsu A; Hayashi T; Alp NJ; Channon KM; Yokoyama M; Kawashima S
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1632-7. PubMed ID: 17463333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
    Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of bleomycin-induced lung fibrosis in mice by a novel approach of parallel inhibition of cyclooxygenase and nitric-oxide donation using NCX 466, a prototype cyclooxygenase inhibitor and nitric-oxide donor.
    Pini A; Viappiani S; Bolla M; Masini E; Bani D
    J Pharmacol Exp Ther; 2012 May; 341(2):493-9. PubMed ID: 22344408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
    Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the nitric oxide system in the anti-atherosclerotic potential of lacidipine in the ApoE-deficient mouse: a morphological, functional, and electrochemical study.
    Cristofori PG; Crivellente FA; Faustinelli I; Lanzoni AR; Lazzarini C; Vecchiato E; Andreoli M; Turton JA; Zancanaro C; Crespi FM
    Toxicol Pathol; 2004; 32(4):493-9. PubMed ID: 15223775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice.
    She ZG; Zheng W; Wei YS; Chen HZ; Wang AB; Li HL; Liu G; Zhang R; Liu JJ; Stallcup WB; Zhou Z; Liu DP; Liang CC
    Circ Res; 2009 May; 104(10):1160-8. PubMed ID: 19359600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice.
    Lee IO; Kratz MT; Schirmer SH; Baumhäkel M; Böhm M
    J Pharmacol Exp Ther; 2012 Nov; 343(2):253-7. PubMed ID: 22837011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo.
    Hoyer FF; Steinmetz M; Zimmer S; Becker A; Lütjohann D; Buchalla R; Zimmer A; Nickenig G
    J Mol Cell Cardiol; 2011 Dec; 51(6):1007-14. PubMed ID: 21884703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardio-protective properties of Ncx-6550, a nitric oxide donating pravastatin, in the mouse.
    Di Filippo C; Monopoli A; Ongini E; Perretti M; D'Amico M
    Microcirculation; 2010 Aug; 17(6):417-26. PubMed ID: 20690980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis.
    Momi S; Monopoli A; Alberti PF; Falcinelli E; Corazzi T; Conti V; Miglietta D; Ongini E; Minuz P; Gresele P
    Cardiovasc Res; 2012 Jun; 94(3):428-38. PubMed ID: 22362817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.